Effects of amifostine on perfused isolated rat heart and on acute doxorubicin-induced cardiotoxicity

Cancer Chemotherapy and Pharmacology

Volumn 43, Issue 3, 1999, Pages 227-232

  Nazeyrollas, Pierre ^a   Prévost, Alain ^b   Baccard, Nathalie ^a   Manot, Leslie ^a   Devillier, Philippe ^a   Millart, Hervé ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b INSTITUT JEAN GODINOT   (France)

Author keywords

Amifostine; Cardioprotection; Cardiotoxicity; Doxorubicin; Isolated rat heart

Indexed keywords

AMIFOSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CELL MEMBRANE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DEPHOSPHORYLATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HEART PERFUSION; HEART PROTECTION; HEMODYNAMICS; ISOLATED HEART; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; VASCULARIZATION;

AMIFOSTINE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CORONARY CIRCULATION; CREATINE KINASE; DOXORUBICIN; HEART; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; OXYGEN CONSUMPTION; RATS; RATS, WISTAR;

EID: 0032951293     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050888     Document Type: Article

References (23)

1. Anderson PG, Digerness SB, Sklar JL, Boor PJ (1990) Use of the isolated perfused heart for evaluation of cardiac toxicity. Toxicol Pathol 18: 497
2. Asayama J, Tanaka T, Tatsumi T, Nakawaga C, Kobara M, Matoba S, Ohta B, Inoue D, Nakagawa M (1995) Effect of doxorubicin on postrest contraction in isolated rat hearts. J Cardiovasc Pharmacol 26: 693
3. Bhanumathi P, Saleesh EB, Vasudevan DM (1992) Creatinine phosphokinase and cardiotoxicity in adriamycin chemotherapy and its modification by WR-1065. Biochem Arch 8: 335
4. Boucek RJ, Buck SH, Scott F, Oquist NL, Fleischer S, Olson RD, Okediji E (1993) Anthracyclin-induced tension in permeabilized cardiac fibers: evidence for activation of the calcium release channel of sarcoplasmic reticulum. J Mol Cell Cardiol 25: 249
5. Calabro-Jones PM, Aguilera JA, Ward JF, Smoluk GD, Fahey RC (1988) Uptake of WR-2721 derivatives by cells in culture: identification of the transported form of the drug. Cancer Res 48: 3634
6. Caldwell RW, Heiffer MH (1975) Acute cardiovascular and autonomic effects of WR-2721: a radioprotective compound. Radiat Res 62: 62
7. Dorr RT, Lagel KE (1994) Anthracycline cardioprotection by amifostine (WR-2721) and its active metabolite (WR-1065) in vitro. Proc Am Soc Clin Oncol 13: 435
8. Fallen EL, Eliot WC, Gerrlin R (1967) Apparatus for study of ventricular function and metabolism in isolated rat heart. J Appl Physiol 22: 836
9. Ganey PE, Carter LS, Mueller RA, Thurman RG (1991) Doxorubicin toxicity in perfused rat heart. Decreased cell death at low oxygen tension. Circ Res 68: 1610
10. Glover DJ, Negendank W, Delivoria-Papadopoulos W, Glick JH (1984) Alterations in oxygen transport following WR-2721. Int J Radiat Oncol Biol Phys 10: 1565
11. Glover DJ, Glick JH, Weiler C, Hurowitz S, Kligerman MM (1986) WR-2721 protects against the haematologic toxicity of cyclophosphamide: a controlled phase II trial. J Clin Oncol 4: 584
12. Kemp G, Rose P, Berman M, Manetta A (1996) Amifostine pretreatment for protection against cyclophosphamide induced and cisplatin induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer. J Clin Oncol 14: 2101
13. Korst AEC, Eeltink CM, Vermorken JB, Van der Vijgh WJF (1997) Pharmacokinetics of amifostine and its metabolites in patients. Eur J Cancer 33: 1425
14. Kusuoka H, Futaki S, Koretsune Y, Kitabatake A, Suga H, Kamada T, Inoue M (1991) Alterations of intracellular calcium homeostasis and myocardial energetics in acute adriamycin-induced heart failure. J Cardiovasc Pharmacol 18: 437
15. Lee V, Randhawa AK, Singal PK (1991) Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals. Am J Physiol 261: H991
16. Montana GS, Anscher MS, Mansbach CM II, Daly N, Delannes M, Clarke-Pearson D, Gaydica EF (1992) Topical application of WR-2721 to prevent radiation-induced proctosigmoiditis. Cancer 69: 2826
17. Pelikan PCD, Weisfeldt ML, Jacobus WE, Miceli MV, Bulkley BH, Gerstenblith G (1986) Acute doxorubicin cardiotoxicity: functional, metabolic and morphologic alterations in the isolated, perfused rat heart. J Cardiovasc Pharmacol 8: 1058
18. Pissarek M, Jänichen F, Blasig IE, Haseloff R, Keller T, Tapp E, Krause EG (1995) Cardioprotective potency of the radical scavenger S-2-(3 aminopropylamino)-ethylphosphorothioic acid in the post-ischaemic rat heart. Mol Cell Biochem 145: 121
19. Pouna P, Bonoron-Adele S, Gouverneur G, Tariosse L, Besse P, Robert J (1995) Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin. Cancer Chemother Pharmacol 35: 257
20. Rabkin SW (1983) Interaction of external calcium concentration and verapamil on the effects of doxorubicin (adriamycin) in the isolated heart preparation. J Cardiovasc Pharmacol 5: 848
21. Ryan SV, Carrithers SL, Parkinson SJ, Skurk C, Nuss C, Pooler PM, Owen CS, Lefer AM, Waldman SA (1996) Hypotensive mechanisms of amifostine. J Clin Pharmacol 36: 365
22. Smoluk GD, Fahey RC, Calabro-Jones PM, Aguilera JA, Ward JF (1988) Radioprotection of cells in culture by WR-2721 and derivatives: form of the drug responsible for protection. Cancer Res 48: 3641
23. Treskes M, Van der Vijgh WJF (1995) WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach. Cancer Chemother Pharmacol 33: 93